These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 26808357)
21. Therapeutic drug monitoring to individualize the dosing of pazopanib: a pharmacokinetic feasibility study. de Wit D; van Erp NP; den Hartigh J; Wolterbeek R; den Hollander-van Deursen M; Labots M; Guchelaar HJ; Verheul HM; Gelderblom H Ther Drug Monit; 2015 Jun; 37(3):331-8. PubMed ID: 25271729 [TBL] [Abstract][Full Text] [Related]
22. Predictive performance of serum digoxin concentration in patients with congestive heart failure by a hyperbolic model based on creatinine clearance. Konishi H; Shimizu S; Chiba M; Minouchi T; Koida M; Yamaji A J Clin Pharm Ther; 2002 Aug; 27(4):257-65. PubMed ID: 12174027 [TBL] [Abstract][Full Text] [Related]
23. Interaction study between digoxin and a preparation of hawthorn (Crataegus oxyacantha). Tankanow R; Tamer HR; Streetman DS; Smith SG; Welton JL; Annesley T; Aaronson KD; Bleske BE J Clin Pharmacol; 2003 Jun; 43(6):637-42. PubMed ID: 12817526 [TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics of digoxin in healthy subjects receiving taranabant, a novel cannabinoid-1 receptor inverse agonist. Denker AE; Morelli G; Vessey LK; Li S; Yuan J; Dunbar S; Lewis NM; Taggart W; Wagner JA Adv Ther; 2009 Feb; 26(2):230-40. PubMed ID: 19219408 [TBL] [Abstract][Full Text] [Related]
25. Effect of exenatide on the steady-state pharmacokinetics of digoxin. Kothare PA; Soon DK; Linnebjerg H; Park S; Chan C; Yeo A; Lim M; Mace KF; Wise SD J Clin Pharmacol; 2005 Sep; 45(9):1032-7. PubMed ID: 16100297 [TBL] [Abstract][Full Text] [Related]
26. Do therapeutic doses of acarbose alter the pharmacokinetics of digoxin? Cohen E; Almog S; Staruvin D; Garty M Isr Med Assoc J; 2002 Oct; 4(10):772-5. PubMed ID: 12389338 [TBL] [Abstract][Full Text] [Related]
27. Effect of lasofoxifene on the pharmacokinetics of digoxin in healthy postmenopausal women. Roman D; Bramson C; Ouellet D; Randinitis E; Gardner M J Clin Pharmacol; 2005 Dec; 45(12):1407-12. PubMed ID: 16291716 [TBL] [Abstract][Full Text] [Related]
28. Impact of reduced P-glycoprotein function on digoxin concentrations in patients with dementia. Ali I; Guidone D; Nicolazzo JA; Brouwer KLR Br J Clin Pharmacol; 2019 Oct; 85(10):2351-2359. PubMed ID: 31269278 [TBL] [Abstract][Full Text] [Related]
29. The effect of telmisartan on the steady-state pharmacokinetics of digoxin in healthy male volunteers. Stangier J; Su CA; Hendriks MG; van Lier JJ; Sollie FA; Oosterhuis B; Jonkman JH J Clin Pharmacol; 2000 Dec; 40(12 Pt 1):1373-9. PubMed ID: 11185636 [TBL] [Abstract][Full Text] [Related]
30. Bioavailability of digoxin tablets in healthy volunteers. Lee CH; Park YJ; Sands CD; Jones DW; Trang JM Arch Pharm Res; 1994 Apr; 17(2):80-6. PubMed ID: 10319136 [TBL] [Abstract][Full Text] [Related]
31. Comparative clinical trial of the variability factors of the exposure indices used for the drug monitoring of two tacrolimus formulations in kidney transplant recipients. Marquet P; Albano L; Woillard JB; Rostaing L; Kamar N; Sakarovitch C; Gatault P; Buchler M; Charpentier B; Thervet E; Cassuto E Pharmacol Res; 2018 Mar; 129():84-94. PubMed ID: 29229354 [TBL] [Abstract][Full Text] [Related]
32. Effect of purple grape juice on the pharmacokinetics of digoxin: Results of a food-drug interaction study . Song X; Ju Y; Zhao H; Qiu W Int J Clin Pharmacol Ther; 2019 Feb; 57(2):101-109. PubMed ID: 30309450 [TBL] [Abstract][Full Text] [Related]
33. Population-based investigation of relative clearance of digoxin in Japanese neonates and infants by multiple-trough screen analysis. Suematsu F; Yukawa E; Yukawa M; Minemoto M; Ohdo S; Higuchi S; Goto Y Eur J Clin Pharmacol; 2001 Apr; 57(1):19-24. PubMed ID: 11372585 [TBL] [Abstract][Full Text] [Related]
34. Multiple doses of the antimuscarinic agent solifenacin do not affect the pharmacodynamics or pharmacokinetics of warfarin or the steady-state pharmacokinetics of digoxin in healthy subjects. Smulders RA; Kuipers ME; Krauwinkel WJ Br J Clin Pharmacol; 2006 Aug; 62(2):210-7. PubMed ID: 16842396 [TBL] [Abstract][Full Text] [Related]
35. Lethal quercetin-digoxin interaction in pigs. Wang YH; Chao PD; Hsiu SL; Wen KC; Hou YC Life Sci; 2004 Jan; 74(10):1191-7. PubMed ID: 14697403 [TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetic interaction of sparfloxacin and digoxin. Johnson RD; Dorr MB; Hunt TL; Conway S; Talbot GH Clin Ther; 1999 Feb; 21(2):368-79. PubMed ID: 10211539 [TBL] [Abstract][Full Text] [Related]
37. Absence of an interaction between tigecycline and digoxin in healthy men. Zimmerman JJ; Harper DM; Matschke K; Speth JL; Raible DG; Fruncillo RJ Pharmacotherapy; 2007 Jun; 27(6):835-44. PubMed ID: 17542766 [TBL] [Abstract][Full Text] [Related]
38. Area under the curve predictions of dalbavancin, a new lipoglycopeptide agent, using the end of intravenous infusion concentration data point by regression analyses such as linear, log-linear and power models. Bhamidipati RK; Syed M; Mullangi R; Srinivas N Xenobiotica; 2018 Feb; 48(2):148-156. PubMed ID: 28290233 [TBL] [Abstract][Full Text] [Related]
39. Effects of Fostamatinib on the Pharmacokinetics of Digoxin (a P-Glycoprotein Substrate): Results From in Vitro and Phase I Clinical Studies. Martin P; Gillen M; Millson D; Oliver S; Brealey C; Elsby R; Baluom M; Lau D; Mant T Clin Ther; 2015 Dec; 37(12):2811-22. PubMed ID: 26514315 [TBL] [Abstract][Full Text] [Related]
40. [Effect of itraconazole on digoxin clearance in patients with congestive heart failure]. Wakasugi H; Ishizuka R; Koreeda N; Yano I; Futami T; Nohara R; Sasayama S; Inui K Yakugaku Zasshi; 2000 Sep; 120(9):807-11. PubMed ID: 11019654 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]